603 related articles for article (PubMed ID: 32853686)
1. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
Singh AK; Singh R
Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia is a strong predictor of poor prognosis in COVID-19.
Liu SP; Zhang Q; Wang W; Zhang M; Liu C; Xiao X; Liu Z; Hu WM; Jin P
Diabetes Res Clin Pract; 2020 Sep; 167():108338. PubMed ID: 32712122
[TBL] [Abstract][Full Text] [Related]
3. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
[TBL] [Abstract][Full Text] [Related]
4. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
[No Abstract] [Full Text] [Related]
5. Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
Singh AK; Singh R
Diabetes Metab Syndr; 2020; 14(5):725-727. PubMed ID: 32473903
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
Kim MK; Jeon JH; Kim SW; Moon JS; Cho NH; Han E; You JH; Lee JY; Hyun M; Park JS; Kwon YS; Choi YK; Kwon KT; Lee SY; Jeon EJ; Kim JW; Hong HL; Kwon HH; Jung CY; Lee YY; Ha E; Chung SM; Hur J; Ahn JH; Kim NY; Kim SW; Chang HH; Lee YH; Lee J; Park KG; Kim HA; Lee JH
Diabetes Metab J; 2020 Aug; 44(4):602-613. PubMed ID: 32794386
[TBL] [Abstract][Full Text] [Related]
7. Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity.
Li G
Diabetes Res Clin Pract; 2020 Oct; 168():108441. PubMed ID: 32926957
[No Abstract] [Full Text] [Related]
8. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G
Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852
[No Abstract] [Full Text] [Related]
9. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
Weis N; Thorsteinsson K; Martinussen C; Madsbad S
Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
[TBL] [Abstract][Full Text] [Related]
10. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.
Wu J; Huang J; Zhu G; Wang Q; Lv Q; Huang Y; Yu Y; Si X; Yi H; Wang C; Liu Y; Xiao H; Zhou Q; Liu X; Yang D; Guan X; Li Y; Peng S; Sung J; Xiao H
BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32503812
[TBL] [Abstract][Full Text] [Related]
11. Commentary: COVID-19 in patients with diabetes.
Hill MA; Mantzoros C; Sowers JR
Metabolism; 2020 Jun; 107():154217. PubMed ID: 32220611
[No Abstract] [Full Text] [Related]
12. Issues for the management of people with diabetes and COVID-19 in ICU.
Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
Cardiovasc Diabetol; 2020 Jul; 19(1):114. PubMed ID: 32690029
[TBL] [Abstract][Full Text] [Related]
13. Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.
Zhou W; Ye S; Wang W; Li S; Hu Q
J Diabetes Res; 2020; 2020():3918723. PubMed ID: 33062712
[TBL] [Abstract][Full Text] [Related]
14. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
[TBL] [Abstract][Full Text] [Related]
15. New-Onset Diabetes in Covid-19.
Rubino F; Amiel SA; Zimmet P; Alberti G; Bornstein S; Eckel RH; Mingrone G; Boehm B; Cooper ME; Chai Z; Del Prato S; Ji L; Hopkins D; Herman WH; Khunti K; Mbanya JC; Renard E
N Engl J Med; 2020 Aug; 383(8):789-790. PubMed ID: 32530585
[No Abstract] [Full Text] [Related]
16. Hyperglycaemia on admission to hospital and COVID-19.
Sardu C; D'Onofrio N; Balestrieri ML; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Paolisso G; Marfella R
Diabetologia; 2020 Nov; 63(11):2486-2487. PubMed ID: 32632527
[No Abstract] [Full Text] [Related]
17. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
Sardu C; D'Onofrio N; Balestrieri ML; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Paolisso G; Marfella R
Diabetes Care; 2020 Jul; 43(7):1408-1415. PubMed ID: 32430456
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.
Ceriello A
Diabetes Res Clin Pract; 2020 May; 163():108186. PubMed ID: 32360400
[No Abstract] [Full Text] [Related]
19. COVID-19 and diabetes: Covidiabetology.
Kalra S; Mittal S
J Pak Med Assoc; 2020 Jun; 70(6):954-955. PubMed ID: 32810084
[No Abstract] [Full Text] [Related]
20. Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era.
Aljehani FA; Funke K; Hermayer KL
Am J Med Sci; 2020 Oct; 360(4):423-426. PubMed ID: 32736827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
